Towards Healthcare
Oncology Devices Market to Rise at 17.84% CAGR till 2034

Oncology Devices Market Developments Shaping Global Healthcare

According to market projections, the oncology devices sector is expected to grow from USD 150.35 billion in 2024 to USD 776.3 billion by 2034, reflecting a CAGR of 17.84%. The increasing prevalence and awareness of cancer and the shift towards personalized medicine have accelerated the importance of medical equipment in the oncology sector. North America dominated the market in 2024, driven by high healthcare expenditure, minimally invasive procedures, and supportive reimbursement policies.

  • Last Updated: 16 October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

FAQ's

The oncology devices market is valued at USD 177.17 billion in 2025 and is on track to reach USD 776.3 billion by 2034, witnessing a steady CAGR of 17.84% during the forecast span.

North America is currently leading the oncology devices market due to the rising cancer incidence, growing health awareness, and advancements in diagnostic technologies.

Some key players include Elekta, Philips, Hologic, Accuray, Stryker, GE Healthcare, etc.

Key trends include liquid biopsy, wearable biosensors, robotic-assisted surgery, etc.

NCI, OCE, ITCR, CFI, CPAC, FDA, WHO, DTIF.